Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer

被引:92
|
作者
Rollin, Jerome
Regina, Sandra
Vourc'h, Patrick
Iochmann, Sophie
Blechet, Claire
Reverdiau, Pascale
Gruel, Yves
机构
[1] Fac Med Tours, INSERM, U618, F-37032 Tours, France
[2] IFR 135, F-37000 Tours, France
[3] INSERM, U619, F-37000 Tours, France
关键词
MMP-2; MMP-9; TFPI-2; non-small cell lung cancer; polymorphism; gene expression; prognosis;
D O I
10.1016/j.lungcan.2006.11.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matrix metalloproteinases (MMP) including MMP-2 and MMP-9 play a major role in tumour invasion by proteolysing the extracellular matrix. Their activation, particularly that of MMP-9, is partly dependent on plasmin that is inhibited by TFPI-2 (tissue factor pathway inhibitor-2), a serine protease inhibitor whose gene expression is decreased in about one-third of non-small cell lung cancers (NSCLC). In addition, MMP-2 and MMP-9 are essential in the development of NSCLC and can be regulated by functional promoter polymorphisms. In this study, the -1306C/T MMP-2, -735C/T MMP-2 and -1562C/T MMP-9 polymorphisms were analysed in 90 NSCLC patients and 90 controls. In addition, the promoter region of the TFPI-2 gene was screened for sequence variations in both groups by DHPLC. A -167G/A polymorphism was identified in 3% of controls whereas none of the 90 patients exhibited this genetic variation in the TFPI-2 promoter region. Moreover, no difference in -1306C/T MMP-2, -735C/T MMP-2 and -1562C/T MMP-9 genotypes was found between cases and controls. However, the homozygous -1562CC MMP-9 genotype was more frequent in patients with squamous cell carcinoma than in controls (p=0.018). When genotype distributions were compared to MMP-2 and MMP-9 gene expression in tumours, no relationship was found with the -1306 MMP-2 and -1562 MMP-9 polymorphisms. In contrast, tumour MMP-2 gene expression was tower in homozygous -735CC patients than in those with CT or TT genotypes. In addition, the survival time was longer in patients with the MMP-2 -735T allele than in those with the CC genotype (p = 0.02). The relative risk of death was increased 2.6-fold in -735CC patients (p = 0.045; 95% CI = 1.0-6.7). The results of this study suggest that the -735C/T MMP-2 polymorphism might be an independent prognostic marker in NSCLC, but this should be confirmed in a larger cohort of patients. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
下载
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [1] Expression and prognostic influence of MMP-2, MMP-9 and TIMP-2 in non-small cell lung cancer
    Cox, G
    Jones, JL
    O'Byrne, KJ
    THORAX, 1999, 54 : A83 - A83
  • [2] Comparative expression of RECK, MMP-2, MMP-9 and VEGF genes in non-small cell lung cancer
    Rollin, J
    Régina, S
    Blechet, C
    Iochmann, S
    Guyétant, S
    Lemarié, E
    Reverdiau, R
    Gruel, Y
    LUNG CANCER, 2005, 49 : S143 - S143
  • [3] Prognostic Impact of MMP-2 and MMP-9 Expression in Pathologic Stage IA Non-Small Cell Lung Cancer
    Shao, Wenlong
    Wang, Wei
    Xiong, Xin-Guo
    Cao, Christopher
    Yan, Tristan D.
    Chen, Guoqin
    Chen, Hanzhang
    Yin, Weiqiang
    Liu, Jun
    Gu, Yingying
    Mo, Mingcong
    He, Jianxing
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (07) : 841 - 846
  • [4] Tumour expression and activity of MMP-2 and MMP-9 metalloproteinases in non-small cell lung cancer according to TFPI-2 gene expression
    Blechet, C
    Rollin, J
    Iochmann, S
    Régina, S
    Lemarié, E
    Reverdiau, P
    Guyétant, S
    Gruel, Y
    LUNG CANCER, 2005, 49 : S117 - S117
  • [5] The MMP-2 and MMP-9 promoter polymorphisms and susceptibility to salivary gland cancer
    Radunovic, Milena
    Nikolic, Nadja
    Milenkovic, Sanja
    Tomanovic, Nada
    Boricic, Ivan
    Dimitrijevic, Milovan
    Novakovic, Ivana
    Basta-Jovanovic, Gordana
    JOURNAL OF BUON, 2016, 21 (03): : 597 - 602
  • [6] Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer
    Iniesta, Pilar
    Moran, Alberto
    De Juan, Carmen
    Gomez, Ana
    Hernando, Florentino
    Garcia-Aranda, Cristina
    Frias, Cristina
    Diaz-Lopez, Antonio
    Rodriguez-Jimenez, Francisco-Javier
    Balibrea, Jose-Luis
    Benito, Manuel
    ONCOLOGY REPORTS, 2007, 17 (01) : 217 - 223
  • [7] Polymorphisms in MMP-2 and MMP-9 promoter regions are associated with endometriosis
    Saare, Merli
    Lamp, Merit
    Kaart, Tanel
    Karro, Helle
    Kadastik, Uelle
    Metspalu, Andres
    Peters, Maire
    Salumets, Andres
    FERTILITY AND STERILITY, 2010, 94 (04) : 1560 - 1563
  • [8] Immunocytochemical expression of matrix metalloprotelnases MMP-2 and MMP-9 in fine needle aspirates of non-small cell lung carcinomas
    Peristeropoulou, P.
    Mendrinou, E.
    Kouli, V
    LUNG CANCER, 2007, 55 : S12 - S12
  • [9] MMP-2 and MMP-9 gene polymorphisms associated with cervical cancer risk
    Zhang, Haiyan
    Li, Guang
    Zhang, Zhen
    Wang, Surong
    Zhang, Shiqian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (12): : 11760 - 11765
  • [10] Prognostic impact of matrix metalloproteinases (MMP-9 and MMP-2) and vascular endothelial growth factor expression in non-small cell lung cancer
    Yurdakul, Ahmet
    Akyurek, Nalan
    Yilmaz, Senay
    Karakaya, Jale
    Memis, Leyla
    Ozturk, Can
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (02) : 281 - 288